CareDx (CDNA) Reports In-Line Q3 EPS

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.01 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies